Stock Plans (Tables)
|
9 Months Ended |
Sep. 30, 2020 |
|---|
| Schedule of Stock-based Compensation Expense |
The Company’s stock-based compensation expense recognized for the periods presented was as follows:
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
|
Stock-based compensation expense by type of award:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock units
|
|
$
|
2,308
|
|
|
$
|
251
|
|
|
$
|
3,203
|
|
|
$
|
748
|
|
|
Restricted stock awards
|
|
|
43
|
|
|
|
47
|
|
|
|
152
|
|
|
|
303
|
|
|
Machine Box contingent common stock issuances
|
|
|
(37
|
)
|
|
|
28
|
|
|
|
(37
|
)
|
|
|
1,255
|
|
|
Performance-based stock options
|
|
|
1,996
|
|
|
|
2,000
|
|
|
|
5,917
|
|
|
|
5,956
|
|
|
Stock options
|
|
|
644
|
|
|
|
2,329
|
|
|
|
4,099
|
|
|
|
7,389
|
|
|
Employee stock purchase plan
|
|
|
157
|
|
|
|
109
|
|
|
|
364
|
|
|
|
398
|
|
|
Total
|
|
$
|
5,111
|
|
|
$
|
4,764
|
|
|
$
|
13,698
|
|
|
$
|
16,049
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
|
Stock-based compensation expense by operating expense grouping:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
$
|
278
|
|
|
$
|
281
|
|
|
$
|
654
|
|
|
$
|
795
|
|
|
Research and development
|
|
|
172
|
|
|
|
334
|
|
|
|
593
|
|
|
|
2,318
|
|
|
General and administrative
|
|
|
4,661
|
|
|
|
4,149
|
|
|
|
12,451
|
|
|
|
12,936
|
|
|
|
|
$
|
5,111
|
|
|
$
|
4,764
|
|
|
$
|
13,698
|
|
|
$
|
16,049
|
|
|
| Schedule of Restricted Stock Award Activity |
The Company’s restricted stock award activity for the nine months ended September 30, 2020 was as follows:
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
Average Grant
|
|
|
|
|
Shares
|
|
|
Date Fair Value
|
|
|
Unvested at December 31, 2019
|
|
|
22,813
|
|
|
$
|
7.50
|
|
|
Granted
|
|
|
5,310
|
|
|
$
|
2.98
|
|
|
Vested
|
|
|
(17,960
|
)
|
|
$
|
6.16
|
|
|
Unvested at September 30, 2020
|
|
|
10,163
|
|
|
$
|
7.50
|
|
|
| Schedule of Restricted Stock Unit Activity |
The Company’s restricted stock unit activity for the nine months ended September 30, 2020 was as follows:
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
Average Grant
|
|
|
|
|
Shares
|
|
|
Date Fair Value
|
|
|
Unvested at December 31, 2019
|
|
|
142,145
|
|
|
$
|
6.71
|
|
|
Granted
|
|
|
835,157
|
|
|
$
|
10.20
|
|
|
Forfeited
|
|
|
(5,500
|
)
|
|
$
|
8.81
|
|
|
Vested
|
|
|
(116,295
|
)
|
|
$
|
6.84
|
|
|
Unvested at September 30, 2020
|
|
|
855,507
|
|
|
$
|
10.09
|
|
|
| Schedule of Stock Option Activity |
The activity during the nine months ended September 30, 2020 related to all other stock options was as follows:
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
Aggregate
|
|
|
|
|
|
|
|
|
Exercise
|
|
|
Contractual
|
|
Intrinsic
|
|
|
|
|
Options
|
|
|
Price
|
|
|
Term
|
|
Value
|
|
|
Outstanding at December 31, 2019
|
|
|
5,196,778
|
|
|
$
|
13.09
|
|
|
|
|
|
|
|
|
Granted
|
|
|
610,000
|
|
|
$
|
3.88
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(59,488
|
)
|
|
$
|
2.89
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(163,634
|
)
|
|
$
|
8.37
|
|
|
|
|
|
|
|
|
Expired
|
|
|
(158,176
|
)
|
|
$
|
14.57
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2020
|
|
|
5,425,480
|
|
|
$
|
12.27
|
|
|
7.1 years
|
|
$
|
6,614
|
|
|
Exercisable at September 30, 2020
|
|
|
4,211,378
|
|
|
$
|
13.81
|
|
|
6.7 years
|
|
$
|
2,376
|
|
|
| Employee Stock Purchase Plan [Member] |
|
| Summary of Fair Value Assumptions of Stock Purchase Plan |
The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the nine months ended September 30, 2020 are set forth in the table below:
|
Expected term (in years)
|
|
0.5 - 2.0
|
|
|
Expected volatility
|
|
65% - 130%
|
|
|
Risk-free interest rate
|
|
0.1% - 1.5%
|
|
|
Expected dividend yield
|
|
|
—
|
|
|
| 2018 Performance Base Stock Incentive Plan [Member] |
|
| Summary of Fair Value Assumptions of Performance Awards |
The assumptions used in the Monte Carlo simulation model for computing the fair values of the Performance Awards on the modification date and immediately before the modification are set forth in the table below:
|
Amendment date stock price
|
|
$
|
8.83
|
|
|
Expected volatility
|
|
|
80
|
%
|
|
Risk-free interest rate
|
|
|
0.6
|
%
|
|
Expected dividend yield
|
|
|
—
|
%
|
|
Cost of equity
|
|
|
12
|
%
|
|
| Stock Options [Member] |
|
| Schedule of Fair Value Assumptions |
The following assumptions were used to compute the grant date fair values of the stock options granted during the nine months ended September 30, 2020:
|
Expected term (in years)
|
|
|
|
6.0 - 6.1
|
|
|
Expected volatility
|
|
|
|
68% - 82%
|
|
|
Risk-free interest rate
|
|
|
|
0.4% - 1.2%
|
|
|
Expected dividend yield
|
|
|
|
|
—
|
|
|
| Performance-based Stock Options [Member] |
|
| Schedule of Stock Option Activity |
The activity during the nine months ended September 30, 2020 related to stock options that are subject to performance-based vesting conditions tied to the future achievement of stock price goals by the Company was as follows:
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
|
|
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
|
Options
|
|
|
Price
|
|
|
Term
|
|
|
Value
|
|
|
Outstanding at December 31, 2019
|
|
|
4,484,739
|
|
|
$
|
16.68
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(298,956
|
)
|
|
$
|
5.65
|
|
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2020
|
|
|
4,185,783
|
|
|
$
|
10.45
|
|
|
7.8 years
|
|
|
$
|
3,507
|
|
|
Exercisable at September 30, 2020
|
|
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
|
$
|
—
|
|
|